For investors

A platform thesis in multisensory brain technology.

The value will concentrate in the layer that synchronizes sensory devices into measurable brain-health and performance programs. Mentalness is building that patent-protected neurocognitive engine above the hardware layer.

U.S. Patent Application Published The Mentalness Synchronized Multisensory Method has reached published U.S. patent-application status, reinforcing the platform’s IP foundation as validation advances.

Why now

AI, XR, biosensing, RF and sensory hardware are converging.

XR, wearables, spatial audio, scent modules, RF systems and biosensors are improving in parallel. AI can now personalize interactions across devices. Mentalness turns this convergence into a synchronized platform for brain training, wellness programs, research validation and future digital therapy.

AI XR biosensing RF and sensory hardware convergence investment thesis

Commercial optionality

Near-term programs with long-term clinical upside.

Consumer programs

Stress recovery, attention training and cognitive resilience programs.

Enterprise

Workforce resilience, executive performance, defense, aviation, education and sports applications.

Longevity clinics

Premium cognitive-health modules for healthspan operators and senior communities.

OEM / SDK

Licensing the SMM synchronization engine into hardware, biosensing and AI platforms.

Clinical pathway

Future SaMD and digital-therapeutic validation in selected indications.

Defensibility

IP, data, science and hardware independence.

IP

Protected methodology

Value is concentrated in the synchronization method, not only in the visible product interface.

Platform

Multiple markets

The same engine can support wellness, clinics, enterprise, SDK and future clinical applications.

Data

Compounding personalization

Repeated sessions can build response profiles that strengthen personalization and the AI roadmap.

Science

Long research foundation

Decades of neuroscience work and protocol know-how are difficult to replicate on a startup sprint.

This page is informational and does not constitute an offer to sell securities. Detailed materials are shared only with qualified investors under appropriate agreements.